Previous studies have shown that antibodies produced against strategic flavivirus epitopes play an important role in recovery and immunity. Definition of the conformation and location of these epitopes and the degree of their conservation among flaviviruses is important to understanding the humoral response to flavivirus infection. In this study we have examined epitopes recognized by 14 monoclonal antibodies (MAbs) produced to the envelope (E) and nonstructural (NS1) proteins of Murray Valley encephalitis virus (MVE). These antibodies were analysed for specificity, neutralization, haemagglutination inhibition (HI) and competitive binding. We have identified six distinct epitopes on the E protein which are located in four non-overlapping domains. MAbs to epitopes in one domain neutralized virus, were specific for MVE and Japanese encephalitis virus, and reacted with epitopes resistant to reduction. Two other E domains, one specific to MVE and the other shared by all flaviviruses, also contained neutralization sites and were stabilized by disulphide bonds. The fourth domain on E was conserved among the flaviviruses, sensitive to SDS denaturation and did not induce neutralizing antibody. Studies with MVE NS 1 MAbs revealed that they were mostly type-specific, unreactive with conserved epitopes, and unreactive in HI and neutralization tests. The six epitopes identified on NS 1 did not overlap and represent antigenic domains either resistant or sensitive to reduction. Immunoblotting of viral proteins in MVE-infected C6/36 cells revealed two distinct forms of NS1 and high Mr proteins of 97K and 108K that represented disulphide-linked heterodimers of E and NS1.
Introduction
The family Flaviviridae includes arthropod-borne viruses which cause human diseases such as yellow fever, dengue and Japanese encephalitis (Monath, 1986) . Murray Valley encephalitis virus (MVE) is a mosquito-transmitted flavivirus native to Australia, Papua New Guinea and possibly Indonesia (Doherty, 1977; Coelen & Mackenzie, 1988) . This virus has been responsible for epidemics and sporadic cases of a severe and sometimes fatal neural disease referred to as Australian encephalitis (Stanley, 1982; Cook, 1987 Cook, , 1988 .
Flavivirus particles are spherical, approximately 40 to 50 nm in diameter and have a lipid envelope surrounding a capsid which contains a single strand positive-sense RNA of approximately 11 kb (Rice et al., 1985; Heinz, 1986) . The envelope protein (E), which may or may not be glycosylated, has an Mr of 50K to 60K and is present on the surface of virus particles as club-like projections t Present address: Department of Microbiology, Queen Elizabeth II Medical Centre, University of Western Australia, Nedlands, W.A. 6009, Australia. (Westaway, 1987) . The immature virion has an additional glycoprotein (prM), of approximately 20K, which during maturation is cleaved to form the membrane protein (M, 8K) (Castle et al., 1985) . In addition to the structural proteins, seven non-structural proteins are synthesized in the infected cell. NS1, a glycoprotein of approximately 40K to 50K, is expressed on the surface of virus-infected cells (Gould et al., 1985) and is secreted by infected Vero, but not C6/36 cells (Mason, 1989) . The NSI protein exists primarily as a homodimer of approximately 90K which can be denatured to form a monomer of approximately 45K (Winkler et al., 1988) . The role of NS1 in viral replication is as yet unknown.
The flavivirus E protein is the major structural antigen, containing B cell epitopes that are either virusspecific, shared by members of the same antigenic complex, or common to the flavivirus family (Trent, 1977; Heinz, 1986) . In contrast, the B cell epitopes on NS1 are less conserved (Gould et al., 1985; Henchal et al., 1987) . Passive protection from lethal challenge has been demonstrated in mice with neutralizing and nonneutralizing monoclonal antibodies (MAbs) to E and 0000-9703 © 1990 SGM prM and with complement-fixing and non-complementfixing MAbs to NS1 (Schlesinger et al., 1985; Heinz, 1986; Hawkes et al., 1988; Henchal et ai., 1988; Kaufman et al., 1989) . This suggests that the mechanisms of in vivo protection include neutralization, lysis of infected cells by antibody-dependent complement-mediated cytolysis and antibody-dependent cytotoxic cells (Heinz, 1986; Gibson et al., 1988) . Additional information on the conformation and location of epitopes involved in these processes and the degree of their conservation is important to the understanding of the humoral immune response to flavivirus infection and the development of flavivirus vaccines.
We have determined the probable spatial arrangement, conformation, viral specificity and some biological properties of epitopes recognized by a panel of MAbs produced to the E and NS1 proteins of MVE. 
Methods
Viruses. A list of the flaviviruses used in this study is given in Table 1 . Virus stocks were prepared as 20% suckling mouse brain suspensions or as infected Vero cell culture supernatants.
Cell culture. Vero and PS/EK cells were grown in HEPES-buffered 199 medium with 10% foetal bovine serum (FBS) and incubated at 37 °C in a humidified atmosphere. C6/36 Aedes albopictus cells were grown in RPMI 1640 with 10% FBS and incubated at 30 °C with humidity. The murine myeloma cell line P3-NS1-Ag4-1 and hybridoma cells were grown in RPMI 1640 with 20% FBS and incubated at 37 °C in a humidified atmosphere with 5% CO2. All media contained streptomycin, penicillin and amphotericin B.
Production of MAbs. To characterize MVE epitopes we produced MAbs to both structural and non-structural viral proteins using a crude suspension of infected suckling mouse brain to immunize mice. Hybridomas were produced to the MVE/3/51 strain by fusing immune spleen cells from BALB/c mice with myeloma cells and culturing the hybrids in selective medium containing hypoxanthine, aminopterin and thymidine. The details of this procedure have been described elsewhere (Galfr6 et al., 1977) . Hybridoma culture supernatants were screened by enzyme immunoassay (EIA) for virus-specific antibody using acetone-fixed, infected C6/36 cell monolayers as antigen (see Hall et aL, t988) .
Characterization of MAbs. Culture supernatants from hybridomas secreting antibody to MVE were tested for reactivity with 14 different flaviviruses in EIA. Fourteen hybridomas were selected for further study on the basis of their specificity and were cloned at least twice by limiting dilution before antibody was produced as ascitic fluid. Each MAb was retested for viral specificity in EIA and examined for haemagglutination inhibition (HI) and neutralizing activity to MVE/3/51 by standard methods (see Hall et al., 1987) . The isotype of each antibody was determined using the Mouse Typer kit (Bio-Rad).
Other antibodies. The hybridoma line D1-4G2-415, which produces antibody to the E protein of DEN-2, was obtained from the American Type Culture Collection. This cell line produces an IgG2a MAb (4G2) that reacts with a flavivirus group-specific epitope and has neutralizing and HI activity (Henchal et al., 1985) . Production and purification of rabbit antibodies to MVE have been previously described (Hall et al., 1987) .
lmmunoblots. The reactivity of each MAb was determined by immunoblotting. Antigens were prepared in confluent monolayers of C6/36 cells infected with MVE and harvested at 48 h post-infection. The cells were washed twice with cold phosphate-buffered saline (PBS) and incubated in lysis buffer (2% Triton X-100, 1% NP40, 1% sodium deoxycholate, 0.1% SDS in PBS pH 7.4) (Gould et al., 1985) at 4 °C overnight and clarified at 10000 g for 30 min. Antigens were boiled in sample buffer (Laemmli, 1970) with or without the addition of 2mercaptoethanol (2ME) and subjected to electrophoresis on 11% polyacrylamide minigels. For identification of the NS1 dimer, cell lysates were not boiled prior to electrophoresis. Uninfected C6/36 cells were similarly processed and used as control antigens. Following PAGE, proteins were transferred to nitrocellulose membranes (Bio-Rad, 0-45 ~tm) (Towbin et al., 1979) . The nitrocellulose sheets were rinsed with PBS containing 0-05% Tween 20, and the non-specific binding sites blocked by incubation for 1 h at room temperature in blocking buffer (0-05 M-Tris-HCI, 0,001 M-EDTA, 0.15 M-NaC1, 0.05 % Tween 20 and 0-2% high nitrogen casein pH 8.0; TENTC). MAbs were diluted in TENTC (ascitic fluid 1/500, culture supernatant 1/5) and allowed to react with bound proteins for 1 h at room temperature. After washing with PBS-Tween, the nitrocellulose strips were incubated with peroxidase-labelled antibodies to mouse IgG [affinity-isolated goat anti-mouse IgG (heavy and light chains); Bio-Rad] at 1/2000 in TENTC buffer for 1 h. After further washings, blots were stained with diaminobenzidine (0-05% in PBS with 0.018% H202) until the desired intensity was reached. Blots were rinsed several times in distilled water before being photographed. Pre-stained Mr standards (Bio-Rad, 17K to 130K) were used to monitor protein transfer and to calculate the approximate size of identified proteins.
Competitive binding studies. Bi-directional competition of binding between monoclonal antibodies was assayed by ELISA. MAbs were conjugated to NHS-LC-biotin [sulphosuccinimidyl-6-(biotinamido) hexanoate; Pierce Chemical Company] by the method of Goding (1986) . MVE antigens in infected suckling mouse brain suspensions were diluted 1/200 in TENTC and captured by purified rabbit anti-MVE antibodies adsorbed to the wells of polyvinyl chloride microtitre plates. Unlabelled MAbs in ascitic fluid were diluted i/5 in TENTC buffer and 50 ~tl was added to each well at room temperature for 1 h. Diluent was used as the control. Without removing the unlabelled antibodies from the wells, 50 txl of biotinylated MAb (1/50 in TENTC) was added, mixed with gentle agitation and incubated for 1 h at room temperature. The plates were washed extensively and bound labelled antibody was detected using Streptavidin-biotin-horseradish peroxidase complex (Amersham) at 1/500 in TENTC buffer. Enzyme activity was detected using I mM-2,2'-azino-bis(3-ethylbenzthiazolinesulphonic acid) with 3 mM-hydrogen peroxide in a citrate/phosphate buffer pH 4.2 as the substrate. The binding capacity of labelled antibody was calculated as the absorbance of the solution at the dual wavelengths of 414 and 492 nm. From these values the percentage of normal binding achieved by each labelled antibody in the presence of unlabelled antibodies was determined (Hall et al., 1988) . Significant competition was acknowledged if binding by the labelled antibody was < 50 %, and promotion was acknowledged if binding was increased by 100%. In these experiments the concentrations of antigen, labelled MAbs and unlabelled MAbs were adjusted so that biotinylated MAbs were completely inhibited by the unlabelled homologous antibody while exhibiting optimum binding capacity in the presence of the diluent control.
Results

Characterization of MVE MAbs
Six M A b s reacted with the NS1 protein of M V E (Table  2) . Four (M-E6, M2-10C6, M2-6H10, M2-10G4) were type-specific for M V E in E I A and two (M2-9A2 a n d M2-8C4) also recognized A L F . These M A b s were unreactive in H I a n d neutralization tests.
Eight M A b s were shown to b i n d to the envelope protein E (Table 3) . One (M2-1H5) was specific for 
Reaction of MVE MAbs in immunoblots
M A b s recognized the NS1 protein of M V E as two diffuse bands in unreduced antigen ( Fig. 1 a and Table 4 ). These b a n d s corresponded to m o n o m e r s of NS1 designated NSI (45K) and N S I ' (53K) (after Mason et aL, 1987) .
A n t i b o d y M2-10G4 reacted only with N S I ' (Fig. 2a ). After reduction of the antigen with 2ME, M A b M2-9A2 reacted with five discrete bands which formed a triplet at 54K, 56K and 58K and a doublet at 47K and 49K (Fig.  1 b) . The a p p e a r a n c e of these doublets and triplets within NS1 and N S I ' was p r o b a b l y due to variation in the n u m b e r of glycosylation sites that were used on these proteins. W h e n the antigens were not boiled or reduced, all six M A b s recognized a diffuse b a n d of 80K to 100K ( Fig. l c, 2c ) that represented the undenatured NS1 d i m e r ( W i n k l e r et al., 1988).
A n t i -E M A b s reacted with an unreduced protein of a p p r o x i m a t e l y 53K in both boiled and unboiled preparations (Fig. 2a, c and Table 5 ). This antigen was confirmed as the envelope glycoprotein E by the reference M A b 4 G 2 (results not shown). M2-1B 12, M2-3B2 and M2-8E7 also reacted with a 55K b a n d in reduced antigen (Fig. 2b) .
Two M A b s (M2-1E7 and M2-6D12) did not react in immunoblots even when the antigens were unreduced and unboiled. However, the strong reactivity of these antibodies in the H I test indicated that they reacted with epitopes on the E protein that were susceptible to SDS denaturation. This conclusion was supported by specific antigen capture studies which revealed that the E protein of M V E was specifically bound by purified M2-1E7 a n t i b o d y adsorbed to the solid phase (results not s h o w n ) .
Nevertheless it is possible that M2-1E7 and M2-6D12 react with HI-reactive epitopes on p r M and that M2-1E7 captures E to the solid phase via E -p r M complexes (Heinz et al., 1983) . reduced indicating they are formed by interprotein disulphide bonds. Such a complex has been observed between the fusion protein (F) and glycoprotein (G) of respiratory syncytial virus (Arumugham et al., 1989) .
Competitive binding assays
Six non-overlapping epitopes were defined on the NS 1 protein (Fig. 3) . One MAb (M2-6H10) was unidirectionally blocked by MAbs reacting with two other epitopes (M2-10C6 and M2-8C4). The binding of M2-9A2 was promoted by the presence of M2-8C4 and M2-6H10 while M-E6 binding was enhanced in the presence of M2-8C4.
Four non-overlapping antigenic domains were observed on the E protein (Fig. 4) . Each domain consisted of a single epitope or clusters of two or three overlapping epitopes. Within these four domains, nine epitopes were identified. Domain El, unique to MVE and JE, was recognized by three MAbs with similar characteristics. One flavivirus group-specific and one partially groupspecific epitope overlapped to form the second domain (E2). The third antigenic domain on the E protein (E3) contained three overlapping epitopes common to the flavivirus family. A fourth domain (E4) specific to MVE was identified by a single MAb (M2-1H5). The binding of MAb (M2-2D8) to its epitope was enhanced in the presence of MAb M2-1H5. All domains induced HI reactive antibodies but only El, E3 and E4 were shown to contain neutralization sites.
Discussion
Our studies have revealed MVE NS1 protein to be present in denatured, infected cell lysates as two distinct monomers (NS1 and NSI'). The heterogeneity of NS1 observed in other flavivirus preparations has been attributed to differences in either the amino acid backbone (Mason et al., 1987) or glycosylation (Young & Falconar, 1989) . Our observation that antibody M2-10G4 reacted with the dimer in unboiled preparations but bound only to the larger NS1 form in boiled antigen suggests that an extra antigenic site occurs on NSI'. Whether this additional epitope occurs in the putative C terminus extension of NSI' as proposed for JE by Mason et al. (1987) or whether it is simply stabilized by the peculiar glycosylation of NSI' is unclear.
NS1 was also observed to form heterodimers with E. These complexes occur in small amounts relative to the monomers of E and NS 1, and apparently have a shortlived function or associate non-specifically at a low frequency. If this association of the non-structural protein NS1 with the surface virion protein E has a role in the life cycle of MVE, it provides further evidence for the possible involvement of NS1 in virion assembly, maturation and/or secretion. Such complexes may explain the presence of minute amounts of envelope protein found in flavivirus NS1 preparations that have been purified by immunoaffinity chromatography (Schlesinger et al., 1986; R. A. Hall, unpublished results) .
Previous antigenic studies using polyclonal antibodies have suggested that flavivirus group-specific epitopes Fig. 6 . Diagrammatic summary of the proposed spatial arrangement, chemical and biological properties and viral specificity of the epitopes recognized on the E protein of MVE. Abbreviations as for Fig. 5 .
exist on the NS1 protein (Schlesinger et al., 1985) . However, the lack of cross-reactions of our MVE NS1 MAbs with other flaviviruses in EIA indicate that a majority of the epitopes recognized on NS 1 were specific to MVE and that none were common to the flavivirus family. Blotting and EIA patterns using culture supernatants from 20 uncloned anti-MVE hybridomas confirmed these observations (results not shown). The antigenic specificities of MVE NS1 epitopes were consistent with the findings of others (Schlesinger et al., 1983; Gould et al., 1985; Henchal et al., 1987) . MAbs to the NS1 protein of MVE, DEN-2 and YF vaccine were often specific to the homologous virus, rarely reacted with more than three other flaviviruses and never reacted with all flaviviruses. The amino acid sequence of the flavivirus NS1 protein is quite conserved, therefore its antigenic specificity is surprising (Coia et al., 1988) . Competitive binding assays using anti-NS1 MAbs, in conjunction with their blotting patterns, enabled us to construct a diagrammatic representation of the conformation and topography of epitopes we identified on this protein (Fig. 5) . One antibody (M2-9A2) defines an epitope on NS1 that maintains its antigenic structure after SDS denaturation and reduction. Five nonoverlapping epitopes lie in regions of the protein that resist denaturation but are susceptible to reduction indicating conformational dependence on disulphide bridges. The unidirectional inhibition of MAb M2-6H 10 by two antibodies that do not interfere with each other indicates that the M2-6H10 epitope is susceptible to conformational changes or lies deep in a protein fold and is readily blocked by antibodies binding to surface epitopes. Conversely, the observation that M2-8C4 was capable of inhibiting or enhancing the binding of three other antibodies indicates that the binding of this MAb induces conformational changes.
Using these criteria we developed a model of the likely conformation and topography of the epitopes on the MVE E protein. Three MAbs, specific for MVE and JE, recognize overlapping epitopes that occur in a portion of the protein that maintains its antigenic structure after reduction (Fig. 6) . These three MAbs are indistinguishable by EIA specificity, blotting pattern or biological function indicating that they bind to a single epitope. On another segment of the protein, epitopes appear to lose their conformation after SDS denaturation, indicating that they are formed as loops or clefts in the folded native protein not stabilized by disulphide bonds. Our EIA results suggest this region of the protein is antigenically conserved among flaviviruses. The remaining epitopes recognized on E lie in a region(s) of the protein that resists SDS denaturation, but is dependent on disulphide bonds for antigenic stability. One domain contains epitopes recognized by three different flavivirus groupreactive MAbs. Another is defined by MAb M2-1H5, which is specific for MVE.
All anti-E MAbs blocked haemagglutination, whereas only MAbs reacting to epitopes that resist SDS denaturation were shown to neutralize the virus. This indicated that four separate sites are involved in haemagglutination and three sites with neutralization. Of particular interest is the group-reactive neutralization site recognized by M2-3H6. This MAb shares a binding site with 4G2 which is indistinguishable from M2-3H6. This epitope is recognized by serum antibodies which develop early in flavivirus infection (Burke et al., 1987; Hall, 1989) . The biological activities of MAbs M2-3H6 and 4G2, and the epitopes they recognize, require further study in relation to neutralization/protection. The possible linear configuration of the epitope recognized by neutralizing MAb M2-8E7 requires confirmation by alkylation experiments before its relevance to synthetic vaccine design can be determined.
The MVE E protein map we have developed is consistent with the model put forward by Roehrig et al. (1989) and similar models for the tick-borne encephalitis virus (TBE) (Heinz et al., 1983; Mandl et al., 1989; Guirakhoo et al., 1989) and WN (Nowak & Wengler, 1987 ) envelope proteins. These models define three or four antigenic domains on the E protein of flaviviruses, present in linear, disulphide-dependent or denaturationsensitive regions. However, anti-TBE MAbs recognized a single group-reactive domain in a denaturationresistant segment of TBE E protein, where we observed conserved epitopes in domains on the E protein of MVE that were both denaturation-sensitive (M2-1E7) and resistant (M2-3H6). The anti-TBE MAbs were produced to detergent-extracted E rosettes (Heinz et al., 1983; Guirakhoo et al., 1989) whereas the MAbs to MVE were produced to live virus. It is possible that the denaturation-sensitive group-reactive site only remains active on the intact virion or large envelope fragments.
In addition to the epitopes we have defined on the E protein of MVE, eight distinct epitopes have been described by Hawkes et al. (1988) . These include four type-specific and subgroup-reactive sites that are not represented by our panel of MVE E MAbs. This suggests that at least 10 distinct epitopes exist on the E protein of MVE.
